Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × OTHER × mitazalimab × Clear all

Phase

Phase 2/3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Cyclophosphamide 413 Radiotherapy 273 fludarabine 233 Gemcitabine 210 Cisplatin 202 Nivolumab 184 pembrolizumab 181 Paclitaxel 175 Carboplatin 167 Magnetic Resonance Spectroscopy 159 fludarabine phosphate 156 Irinotecan 134 Bevacizumab 132 Cytarabine 128 Capecitabine 124 Temozolomide 123 Radiosurgery 117 Specimen Handling 116 Docetaxel 116 Ipilimumab 113 Dexamethasone 113 Biopsy 110 Radiation 109 Oxaliplatin 109 Fluorouracil 109 Etoposide 108 Rituximab 106 Filgrastim 99 Lenalidomide 98 Everolimus 96

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05650918 2023-10-12

REACtiVe-2

Erasmus Medical Center

Phase 1 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡